Company Overview
Snapshot
Founded in February 2019 by Miron Hazani, Roxx Labs operates with 1–10 employees. The company is currently in the Pre-Funding stage, focusing on developing its proprietary aqueous cannabis vaporizer. Roxx Labs has successfully tested its technology and is completing product design for manufacturing.
Business overview
Roxx Labs develops an aqueous cannabis vaporizer designed for metered dosing and improved delivery of cannabis to the lungs. Its core technology focuses on a proprietary system that is free of oil, propylene glycol (PG), vegetable glycerin (VG), and other toxic materials, producing a submicron mist. The company operates in the Health Tech & Life Sciences sector, specifically within Pharma & Medical Biotechnology, focusing on drug delivery and medical cannabis, serving both B2C and B2B markets globally.
Log in to access full profile ›Company Intelligence Q&A
- What is Roxx Labs' primary product?
- Roxx Labs has developed a proprietary aqueous cannabis vaporizer that delivers cannabis to the lungs via a submicron mist, free of common additives like oil, propylene glycol, and vegetable glycerin.
- When was Roxx Labs founded?
- Roxx Labs was founded in February 2019.
- Who is a co-founder of Roxx Labs?
- Miron Hazani is a co-founder and CTO of Roxx Labs.
- What stage of development is Roxx Labs' product in?
- Roxx Labs has successfully tested its technology and is currently completing product design for manufacturing, indicating it is in the Alpha product stage.
- What markets does Roxx Labs target?
- Roxx Labs targets both B2C and B2B markets globally, focusing on the medical cannabis and recreational & lifestyle cannabis segments.